Does innate immune response defect underlie inflammatory bowel disease in the Asian population?

Postgraduate Medical Journal

Volumn 81, Issue 958, 2005, Pages 483-485

  Lanzarotto, F ^a   Akbar, A ^a   Ghosh, S ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; ANTIGEN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD14 ANTIGEN; FOOD ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROTEIN ANTIBODY; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ANTIBODY;

ANTIGENICITY; ASIA; CROHN DISEASE; EDITORIAL; ENTERITIS; GENE CONTROL; GENE EXPRESSION; GENETIC DISORDER; HUMAN; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; LIFESTYLE; MICROFLORA; POPULATION RESEARCH; ULCERATIVE COLITIS;

ASIAN CONTINENTAL ANCESTRY GROUP; COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; TOLL-LIKE RECEPTORS;

EID: 23844468853     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2005.036590     Document Type: Editorial

References (26)

1. Hugo JP, Chamaillade M, Zou Ali H, et al. Association of NOD2 leonine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
2. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
3. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003;278:5509-12.
4. Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-7.
5. Franchimont D, Vermiere S, Housni HE, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004;53:987-92.
6. Gazouli M, Mantzaris G, Kotsinas A, et al. Association between polymorphisms in the toll-like receptor 4, CD14 and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 2005;11:681-5.
7. Torok H-P, Glas J, Tonenchi L, et al. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 2004;112:85-91.
8. Jiang Q, Akashi S, Miyake K, et al. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J Immunol 2000;165:3541-4.
9. Lakatos PL, Lakatos L, Szalay F, et al. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease:phenotype- genotype correlations. World J Gastroenterol 2005;14:1489-95.
10. Klein W, Tromm A, Griga T, et al. A polymorphism in the CD14 gene is associated with Crohn's disease. Scand J Gastroenterol 2002;37:189-91.
11. Obana N, Takahashi S, Kinouchi Y, et al. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol 2002;37:699-704.
12. Leong RWL, Lau JY, Sung JJY. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis 2004;10:646-51.
13. Leong RWL, Armuzzi A, Ahmad T, et al. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 2003;17:1465-70.
14. Guo QS, Xia B, Morre SA, et al. Polymorphisms of CD14 gene and TLR4 are not associated with ulcerative colitis in Chinese patients. Postgrad Med J 2005;81:526-9.
15. Okayama N, Fujimura K, Suehiro Y, et al. Simple genotype analysis of the Asp299 polymorphism of the toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness. J Clin Lab Anal 2002;16:56-8.
16. Watanabe T, Kitani A, Murray PJ, et al. NOD2 is a negative regulator of toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004;5:800-8.
17. Maeda S, Hsu LC, Liu H, et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005;307:734-8.
18. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005;307:731-4.
19. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:671-4.
20. Van Heel DA, Ghosh S, Butler M, et al. Muramyl dipeptide and toll-like receptor sensitivity in NOD2 associated Crohn's disease. Lancet (in press).
21. Netea M, Kullberg BJ, de Jong DJ, et al. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands:implications for Crohn's disease. Eur J Immunol 2004;34:2052-9.
22. Butler M, Na C-Y, Lombardi G, et al. Intestinal epithelial cells modulate the phenotype and function of monocyte-derived dendritic cells in an in vitro model. Digestive Diseases Week, Chicago, 2005.
23. Rimoldi M, Chieppa M, Salucci V, et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nature Immunol 2005;6 (online publication 10 Apr 2005).
24. +, and double-negative Peyer's patch dendritic cells. J Immunol 2001;166:4884-90.
25. + Peyer's patch dendritic cells secrete IL-6 and induce IgA secretion from naïve B cells. J Immunol 2003;171:3684-90.
26. Armitage EL, Aldhous MC, Anderson N, et al. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology 2004;127:1051-7.